Correction: Infliximab for pediatric patients with Crohn's disease: A Phase 3, open-label, uncontrolled, multicenter trial in Japan.

Tajiri, Hitoshi; Motoya, Satoshi; Kinjo, Fukunori; Maemoto, Atsuo; Matsumoto, Takayuki; Sato, Noriko; Yamada, Hiroshi; Nagano, Mieko et al. · PLoS One · 2022

Where this comes from

Record sourced from PubMed, PMID 35439252.
Also identified by DOI 10.1371/journal.pone.0261932 and PMC identifier 9017882.
No licence information is recorded for this record.
Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0201956.].

Read the full text

View on PubMed · Publisher (DOI)